Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Influence of the 1976T>C Polymorphism in the Adenosine A2A Receptor Gene on Adenosine-Induced Vasodilation and the Influence of the 34C>T Polymorphism in the AMP Deaminase Gene on Post-Occlusive Reactive Hyperemia.

NCT00253929 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT00253929
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00253929 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Influence of the 1976T>C Polymorphism in the Adenosine A2A Receptor Gene on Adenosine-Induced Vasodilation and the Influence of the 34C>T Polymorphism in the AMP Deaminase Gene on Post-Occlusive Reactive Hyperemia.
Lead sponsor
Radboud University Medical Center
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2005
Completion date
February 28, 2006
Enrollment
100
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood flow in healthy volunteers